Reuters logo
IP experts testify before Congress on Allergan tribal patent deal
November 7, 2017 / 11:57 PM / in 17 days

IP experts testify before Congress on Allergan tribal patent deal

A congressional subcommittee on Tuesday heard testimony from intellectual property experts about the validity of drugmaker Allergan PLC’s agreement with a Native American tribe to shield patents from review by the Patent Trial and Appeal Board.

The House Judiciary Committee’s subcommittee on IP held a hearing to address whether Congress should take action to limit sovereign immunity in PTAB cases.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2iC6hRG

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below